Maven Securities’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,000	Closed	-$33.9K	–	507
2022 Q4	$33.9K	Buy	+15,000	New	+$33.9K	﹤0.01%	203
2020 Q4	–	Sell	-11,784	Closed	-$277K	–	697
2020 Q3	$277K	Buy	+11,784	New	+$277K	0.02%	292